The effect of systemic erythropoietin and oral prednisolone on recent-onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial
- 6 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Albrecht von Graefes Archiv für Ophthalmologie
- Vol. 258 (10), 2291-2297
- https://doi.org/10.1007/s00417-020-04781-x
Abstract
Background To evaluate the effect of systemic erythropoietin, as well as oral steroids, in the management of recent-onset non-arteritic anterior ischemic optic neuropathy (NAION). Method Patients diagnosed with NAION within 5 days were randomized into group A (systemic erythropoietin), group B (oral steroids), and group C (control). Group A received 10,000 units of erythropoietin twice a day for 3 days. Group B received oral prednisone 75 mg daily tapered off in 6 weeks. Results The mean best-corrected visual acuity (± SD) at the time of presentation was 1 ± 0.56, 1.01 ± 0.6, and 0.94 ± 0.47 logMAR in groups A, B, and C, respectively (P = 0.140); corresponding values at 6-month follow-up were 0.70 ± 0.44, 0.73 ± 0.35, and 0.75 ± 0.39 logMAR, respectively (P = 0.597). Fifty-five percent of patients in group A versus 34.3% in group B and 31.2% in group C had an improvement of at least 3 lines in the best-corrected visual acuity values at the 6th month of follow-up visit (P = 0.04). Peripapillary retinal nerve fiber layers at presentation were 189 ± 58, 193 ± 64, and 199 ± 62 micrometers, respectively (P = 0.779), which decreased to 88 ± 12, 74 ± 25, and 71 ± 18, respectively at 6-month follow-up (P = 0.041). Conclusion The findings of our study indicate the beneficial effects of systemic erythropoietin in preserving the function and structure of the optic nerve in recent-onset NAION. Trial registration Clinical registration number: IR.SBMU.ORC.REC.1397.18Keywords
This publication has 28 references indexed in Scilit:
- Nonarteritic Anterior Ischemic Optic Neuropathy (NAION): A Misnomer. Rearranging Pieces of a Puzzle to Reveal a Nonischemic Papillopathy Caused by Vitreous SeparationOphthalmology, 2015
- Erythropoietin: a novel treatment for traumatic optic neuropathy—a pilot studyAlbrecht von Graefes Archiv für Ophthalmologie, 2010
- Faculty Opinions recommendation of Treatment of nonarteritic anterior ischemic optic neuropathy.Published by H1 Connect ,2010
- The Use of Hyperbaric Oxygen Therapy in OphthalmologySurvey of Ophthalmology, 2008
- Intravitreal Triamcinolone Improves Recovery of Visual Acuity in Nonarteritic Anterior Ischemic Optic NeuropathyJournal of Neuro-Ophthalmology, 2007
- Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma MiceInvestigative Ophthalmology & Visual Science, 2007
- Optic disc edema in non-arteritic anterior ischemic optic neuropathyAlbrecht von Graefes Archiv für Ophthalmologie, 2007
- Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trialAlbrecht von Graefes Archiv für Ophthalmologie, 2005
- Does Levodopa improve visual function in NAION?Ophthalmology, 2000
- Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis.British Journal of Ophthalmology, 1974